by María Álvarez | Dec 11, 2018 | Investors, R+D
Europa Press | December 05, 2018 The biotechnology company Derma Innovate has opened a round of funding in the crowdfunding platform ‘Capital Cell’, which aims to raise 400,000 euros to be able to validate their clinical trials on skin and hair...
by María Álvarez | Aug 24, 2018 | R+D
Isquaemia Biotech, a company owned by Canaan Reserch & Investment, an investment company specializing in the biotechnology sector, together with the Autonomous University of Madrid and the Higher Council of Scientific Research have signed a license agreement for...
by María Álvarez | Aug 24, 2018 | R+D
09/10/2015 Researchers of the Experimental Dermatology and Cutaneous Biology Group of the Ramón y Cajal Institute of Health Research -IRYCIS- of the Ramón y Cajal University Hospital have shown for the first time, how the production of reactive oxygen species in a...
by María Álvarez | Aug 24, 2018 | Investigación, R+D
An investigation of the Hospital Ramón y Cajal shows that it is possible to use reactive oxygen species, highly toxic, to activate the proliferation of skin stem cells Thanks to the use of reactive oxygen species (ROS), usually toxic and related to aging, hair growth...
by María Álvarez | Aug 24, 2018 | Investigación, Uncategorized
18/07/2018 Dr. Vañó stressed that “capillary cloning is the great therapeutic novelty in patients with androgenic alopecia, the most frequent form of baldness that affects 70% of men and 30% of women.” . Hair cloning, a therapy with stem cells for...
